Lyerly co-authors article in Science about ethics of Zika human challenge trial

The policy forum piece co-authored by Anne Drapkin Lyerly, MD, explores the question of whether a Zika human challenge trial (intentionally infecting people with Zika to address the science and vaccine development process) could be ethically justified.

Lyerly co-authors article in Science about ethics of Zika human challenge trial click to enlarge Anne Drapkin Lyerly, MD

Anne Drapkin Lyerly, MD, is one of the co-authors of a policy forum article published in the April 13, 2018 issue of Science.  The article explores the question of whether a Zika human challenge trial (intentionally infecting people with Zika to address the science and vaccine development process) could be ethically justified.  

This article stems from an expert panel, including Dr. Lyerly, that was convened by the National Institutes of Health to consider that question. The panel concluded that there was insufficient value to justify a Zika human challenge trial at the time of their report.

"The article in Science is much shorter piece on what we learned from the process that might advance ethics guidance for research more generally," says Dr. Lyerly, a professor of social medicine and obstetrics and gynecology and associate director of the UNC Center for Bioethics. 

You can read the full article at: http://science.sciencemag.org/content/360/6385/158